Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Cough, Cold and Allergy (Hay Fever) Remedies in Belgium

Belgium cough remedies market: Key players include Procter & Gamble Eurocor, Solinest & Novartis Consumer Health


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-04-18 15:31:04 - Cough, Cold and Allergy (Hay Fever) Remedies in Belgium - a new market research report on companiesandmarkets.com

Although it is fragmented in terms of brands, the competitive landscape in the Belgium cough remedies market is concentrated in terms of companies. The top five players, namely Procter & Gamble Eurocor, Solinest, Novartis Consumer Health, Sanofi-Synthélabo and Melisana, accounted for a 41% share of overall value sales in 2012. Procter & Gamble led in 2012 with a 14% value share, by virtue of the high profile and strong sales of its Vicks umbrella brand. It is present in many categories, including decongestants, but also medicated confectionery – included both in medicated confectionery and packaged food.

2012 ended better for cough, cold and allergy (hay fever) remedies than it started. The winter was not particularly cold, with limited falls in temperatures

 

 

– this did not act in favour of the number and intensity of flu cases. However, the spring and the summer were cool and rainy, and frequent temperature variations boosted the number of colds, and to a lesser extent coughs. However, many years after the questioning of combination cough, cold and allergy remedies – as a result of which most were withdrawn – the category was again questioned by the Commission des Médicaments, particularly paediatric variants, from 2011.

In spite of the climate of deregulation that was in the air in 2010/2011, the outlook is again rather grey for cough, cold and allergy (hay fever) remedies. Before mid-2011, the recent emergence of sales via the internet – authorised since January 2009 – was promising; nonetheless, almost all products will still be sold through chemists/pharmacies in the coming years. With the questioning of paediatric dextromethorphan products and the reverse switch of Cirrus from Bios Coutelier, there is again a negative climate surrounding combination OTC products in Belgium.

Click for report details: www.companiesandmarkets.com/Market/Consumer-Goods/Market-Researc ..

Browse all Consumer Goods Market Research Reports www.companiesandmarkets.com/Market/Consumer-Goods/Market-Researc ..

Browse all Consumer Goods Company Profile Reports www.companiesandmarkets.com/Market/Consumer-Goods/Company-Profil ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com